Dana, N., Vaseghi, G., & haghjooy javanmard, shaghayegh. (2019). PPAR γ agonist, pioglitazone, suppresses melanoma cancer in mice by inhibiting TLR4 signaling. Journal of Pharmacy & Pharmaceutical Sciences, 22(1), 418–423. https://doi.org/10.18433/jpps30626